Status: Recruiting
Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).
Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: Up to 72Biological sex: AllType: InterventionalSponsor: Instituto de Investigación Hospital Universitario La PazUpdated: Mar 17, 2025Locations: 3
Eligibility criteria
Born with up to 32(+6) weeks gestation [+2]
Neonates considered non-viable, with a clinical decision not to provide life sup... [+5]